ARID1A and endometrium neoplasm: The molecular profiles obtained from the TCGA 2013 endometrioid endometrial carcinoma tumor set (n = 193) were similar to the endometrioid SEO molecular profiles (n = 32) for both the endometrial and ovarian counterparts, except for a higher frequency of ARID1A mutations in the endometrial tumors.